Shoko Norimura, Keiichi Kontani, Takako Kubo, Shin-Ichiro Hashimoto, Chisa Murazawa, Koichiro Kenzaki, Dage Liu, Masafumi Tamaki, Fuminori Aki, Kazumasa Miura, et al. Candidate biomarkers predictive of anthracycline and taxane efficacy against breast cancer. Journal of Cancer Research and Therapeutics. 2018. 14. 2. 409-415
紺谷桂一, 横見瀬裕保. Metronomic chemotherapy for metastatic breast cancer to prolong time to treatment failure to 12 months or more. Mol. Clin. Oncol. 2013. 1. 2. 225-230
Identification of prognostic factors responsible for long-term survival in metastatic breast cancer
(The 11th international conference of the Asian Clinical Oncology Society 2014)
Detection of prognostic factors in metastatic breast cancer from the result comparing clinicopathological factors between long survivors and short survivors
(Global Breast Cancer Conference 2013 2013)
乳癌におけるTrastuzumab効果予測因子
(第112回日本外科学会学術総会 2012)
当科におけるセンチネルリンパ節陽性例の検討
(第20回日本乳癌学会学術総会 2012)
転移再発乳癌に対するtime to treatment failure延長を目指した治療戦略
(第20回日本乳癌学会学術総会 2012)